A pharmaceutical unit in Ahmedabad has filed a forgery case against three medical representatives for allegedly submitting fake prescriptions to promote their products. The company discovered discrepancies in the prescriptions provided by the representatives during a routine audit. The medical representatives are accused of forging prescriptions to boost sales of certain medications. The pharmaceutical unit has stated that such fraudulent activities can have serious consequences on public health and safety. The case has been registered under relevant sections of the Indian Penal Code, and an investigation is underway to determine the extent of the forgery. This incident serves as a reminder of the importance of maintaining ethical standards in the pharmaceutical industry. Companies need to ensure that their representatives adhere to regulations and guidelines to protect the integrity of the healthcare system. The pharmaceutical unit has urged other companies to be vigilant and conduct regular audits to prevent similar fraudulent activities. It is crucial for the industry to maintain transparency and trust to safeguard the well-being of patients. This case highlights the need for stricter measures to prevent forgery and malpractice in the pharmaceutical sector. Authorities are working to hold the individuals involved accountable for their actions and to prevent such incidents in the future.